Literature DB >> 4303671

Neutralization kinetics of poliovirus by specific antiserum during the course of immunization of rabbits.

Y Ozaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4303671     DOI： 10.1007/bf01258160

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  13 in total

1.  Antigenic characterization of oral poliovaccine progeny by neutralization kinetics.

Authors:  Y OZAKI; A R DIWAN; W D McBRIDE; J L MELNICK
Journal:  J Immunol       Date:  1963-02       Impact factor: 5.422

2.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

3.  Neutralization of viral infectivity: characterization of the virus-antibody complex, including association, dissociation, and host-cell interaction.

Authors:  B MANDEL
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

4.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus.

Authors:  R DULBECCO; M VOGT; A G STRICKLAND
Journal:  Virology       Date:  1956-04       Impact factor: 3.616

5.  Factors influencing the proliferation of viruses.

Authors:  J L MELNICK; G D HSIUNG; C RAPPAPORT; D HOWES; M REISSIG
Journal:  Tex Rep Biol Med       Date:  1957

6.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation.

Authors:  N K JERNE; P AVEGNO
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

7.  Virus aggregation as the cause of the non-neutralizable persistent fraction.

Authors:  C Wallis; J L Melnick
Journal:  J Virol       Date:  1967-06       Impact factor: 5.103

8.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. III. SEQUENTIAL CHANGES IN ELECTROPHORETIC MOBILITY OF 19S AND 7S ANTIBODIES SYNTHESIZED BY RABBITS AFTER A SINGLE VIRUS INJECTION.

Authors:  S E SVEHAG
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

10.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.

Authors:  S E SVEHAG; B MANDEL
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307
View more
  7 in total

1.  Intranuclear crystal formation in picornavirus-infected cells.

Authors:  M Kawanishi
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Analysis of poliovirus antibody complexes by density gradient centrifugation.

Authors:  M Kawanishi; Y Ozaki
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Studies on the neutralization of Japanese encephalitis virus. 3. Analysis of the neutralization reaction by anti-rabbit-gamma-globulin serum.

Authors:  Y Ozaki; K Kumagai; M Kawanishi; A Seto
Journal:  Arch Gesamte Virusforsch       Date:  1974

4.  Radioimmunoelectrophoretic identification of poliovirus inhibitors and their characteristic mode of action.

Authors:  S Urasawa; T Urasawa; M Kanamitsu
Journal:  Arch Gesamte Virusforsch       Date:  1971

5.  [Plaque-reduction test for the determination of serum virus-neutralization potency].

Authors:  A Grafe
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

Review 6.  Monoclonal antibodies: implications for virology. Brief review.

Authors:  K C McCullough
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 7.  Neutralization of animal viruses.

Authors:  B Mandel
Journal:  Adv Virus Res       Date:  1978       Impact factor: 9.937
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.